More articles from Perspective

You have access
Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk
Nadine Kabbani and James L. Olds

Molecular Pharmacology May 2020, 97 (5) 351-353; DOI: https://doi.org/10.1124/molpharm.120.000014
You have access
The Molecular Pharmacology of G Protein Signaling Then and Now: A Tribute to Alfred G. Gilman
Roger K. Sunahara and Paul A. Insel

Molecular Pharmacology May 2016, 89 (5) 585-592; DOI: https://doi.org/10.1124/mol.116.104216
You have access
Casting a Wider Net: Whole-Cell Assays to Capture Varied and Biased Signaling
Terry Kenakin

Molecular Pharmacology October 2012, 82 (4) 571-574; DOI: https://doi.org/10.1124/mol.112.081117
You have access
How Can 1 + 1 = 3? β₂-Adrenergic and Glucocorticoid Receptor Agonist Synergism in Obstructive Airway Diseases
Martina Schmidt and Martin C. Michel

Molecular Pharmacology December 2011, 80 (6) 955-958; DOI: https://doi.org/10.1124/mol.111.075481
You have access
Paradoxical Stimulatory Effects of the “Standard” Histamine H₄-Receptor Antagonist JNJ7777120: the H₄ Receptor Joins the Club of 7 Transmembrane Domain Receptors Exhibiting Functional Selectivity
Roland Seifert, Erich H. Schneider, Stefan Dove, Irena Brunskole, Detlef Neumann, Andrea Strasser and Armin Buschauer

Molecular Pharmacology April 2011, 79 (4) 631-638; DOI: https://doi.org/10.1124/mol.111.071266
You have access
Flapping Loops: Roles for Hinges in a Ligand-Binding Domain of the Nicotinic Receptor
Joe Henry Steinbach

Molecular Pharmacology March 2011, 79 (3) 337-339; DOI: https://doi.org/10.1124/mol.110.070102
You have access
Endocannabinoid Overload
Aron H. Lichtman, Jacqueline L. Blankman and Benjamin F. Cravatt

Molecular Pharmacology December 2010, 78 (6) 993-995; DOI: https://doi.org/10.1124/mol.110.069427
You have access
Mind Your Salts: When the Inactive Constituent Isn't
Richard R. Neubig

Molecular Pharmacology October 2010, 78 (4) 558-559; DOI: https://doi.org/10.1124/mol.110.067645
You have access
G Protein-Mediated Inhibition of Ca_v3.2 T-Type Channels Revisited
Edward Perez-Reyes

Molecular Pharmacology February 2010, 77 (2) 136-138; DOI: https://doi.org/10.1124/mol.109.062133
You have access
An Ion Channel Hypothesis to Explain Divergent Cardiovascular Safety of Cyclooxygenase-2 Inhibitors: The Answer to a Hotly Debated Puzzle?
Mark S. Shapiro

Molecular Pharmacology November 2009, 76 (5) 942-945; DOI: https://doi.org/10.1124/mol.109.059683

Main menu

User menu

Search

More articles from Perspective

Pages

Navigate

More Information

ASPET's Other Journals